AMEX:LCTX
Lineage Cell Therapeutics, Inc.
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
www.lineagecell.comipo date
Mar 05, 1992
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-related macular degeneration; OPC1,...Show More
Earnings
Earnings Release in 12 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus